These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2870156)

  • 21. Development of prednisone:polyethylene glycol 6000 fast-release tablets from solid dispersions: solid-state characterization, dissolution behavior, and formulation parameters.
    Leonardi D; Barrera MG; Lamas MC; Salomón CJ
    AAPS PharmSciTech; 2007 Dec; 8(4):E108. PubMed ID: 18181529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of drug solubility on in vitro availability rate from suppositories with polyethylene glycol excipients.
    Realdon N; Ragazzi E; Ragazzi E
    Pharmazie; 2001 Feb; 56(2):163-7. PubMed ID: 11234347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Species differences in size discrimination in the paracellular pathway reflected by oral bioavailability of poly(ethylene glycol) and D-peptides.
    He YL; Murby S; Warhurst G; Gifford L; Walker D; Ayrton J; Eastmond R; Rowland M
    J Pharm Sci; 1998 May; 87(5):626-33. PubMed ID: 9572915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of polyethylene glycol chain length on compatibility and release characteristics of ternary solid dispersions of itraconazole in polyethylene glycol/hydroxypropylmethylcellulose 2910 E5 blends.
    Janssens S; Denivelle S; Rombaut P; Van den Mooter G
    Eur J Pharm Sci; 2008 Oct; 35(3):203-10. PubMed ID: 18656535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative bioavailability study of acetaminophen solutions used in hospital formulary.
    Prakongpan S; Puncoke R; Nagai T
    Biol Pharm Bull; 1993 Jun; 16(6):613-5. PubMed ID: 8364517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physicochemical characterisation, drug polymer dissolution and in vitro evaluation of phenacetin and phenylbutazone solid dispersions with polyethylene glycol 8000.
    Khan S; Batchelor H; Hanson P; Perrie Y; Mohammed AR
    J Pharm Sci; 2011 Oct; 100(10):4281-94. PubMed ID: 21560130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipidic dispersion to reduce food dependent oral bioavailability of fenofibrate: In vitro, in vivo and in silico assessments.
    O'Shea JP; Faisal W; Ruane-O'Hora T; Devine KJ; Kostewicz ES; O'Driscoll CM; Griffin BT
    Eur J Pharm Biopharm; 2015 Oct; 96():207-16. PubMed ID: 26215636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer on bioadhesion and release rate property of eplerenone pellets.
    Kendre PN; Chaudhari PD
    Drug Dev Ind Pharm; 2017 May; 43(5):751-761. PubMed ID: 27494543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Free flowing solid dispersions of the anti-HIV drug UC 781 with Poloxamer 407 and a maximum amount of TPGS 1000: investigating the relationship between physicochemical characteristics and dissolution behaviour.
    Goddeeris C; Van den Mooter G
    Eur J Pharm Sci; 2008 Sep; 35(1-2):104-13. PubMed ID: 18644442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between dissolution rate and bioavailability of paracetamol tablet.
    Huang XP; Wan XX; Liu Q
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Apr; 23(4):367-8, 371. PubMed ID: 12697478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Excipient-mediated alteration in drug bioavailability in the rat depends on the sex of the animal.
    Mai Y; Afonso-Pereira F; Murdan S; Basit AW
    Eur J Pharm Sci; 2017 Sep; 107():249-255. PubMed ID: 28709912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dissolution and bioavailability enhancement of alpha-asarone by solid dispersions via oral administration.
    Deng L; Wang Y; Gong T; Sun X; Zhang ZR
    Drug Dev Ind Pharm; 2017 Nov; 43(11):1817-1826. PubMed ID: 28665158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of binary and ternary solid dispersions on the in vitro dissolution and in-situ rabbit intestinal absorption of gliclazide.
    El-Maghraby GM; Alomrani AH
    Pak J Pharm Sci; 2011 Oct; 24(4):459-68. PubMed ID: 21959805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of vehicle dielectric properties on acetaminophen bioavailability from polyethylene glycol suppositories.
    Pagay SN; Poust RI; Colaizzi JL
    J Pharm Sci; 1974 Jan; 63(1):44-7. PubMed ID: 4811284
    [No Abstract]   [Full Text] [Related]  

  • 35. Soluplus®/TPGS-based solid dispersions prepared by hot-melt extrusion equipped with twin-screw systems for enhancing oral bioavailability of valsartan.
    Lee JY; Kang WS; Piao J; Yoon IS; Kim DD; Cho HJ
    Drug Des Devel Ther; 2015; 9():2745-56. PubMed ID: 26045660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physical stability of solid dispersions containing triamterene or temazepam in polyethylene glycols.
    Dordunoo SK; Ford JL; Rubinstein MH
    J Pharm Pharmacol; 1997 Apr; 49(4):390-6. PubMed ID: 9232536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular interaction between glimepiride and Soluplus®-PEG 4000 hybrid based solid dispersions: Characterisation and anti-diabetic studies.
    Reginald-Opara JN; Attama A; Ofokansi K; Umeyor C; Kenechukwu F
    Int J Pharm; 2015 Dec; 496(2):741-50. PubMed ID: 26581773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancement of solubility, dissolution and bioavailability of ibuprofen in solid dispersion systems.
    Newa M; Bhandari KH; Kim JO; Im JS; Kim JA; Yoo BK; Woo JS; Choi HG; Yong CS
    Chem Pharm Bull (Tokyo); 2008 Apr; 56(4):569-74. PubMed ID: 18379109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modification of crystallization behavior in drug/polyethylene glycol solid dispersions.
    Zhu Q; Harris MT; Taylor LS
    Mol Pharm; 2012 Mar; 9(3):546-53. PubMed ID: 22299821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of polysorbate 80 on the in-vitro precipitation and oral bioavailability of halofantrine from polyethylene glycol 400 formulations in rats.
    Tønsberg H; Holm R; Bisgaard J; Jacobsen J; Müllertz A
    J Pharm Pharmacol; 2010 Jan; 62(1):63-70. PubMed ID: 20723000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.